Incannex Healthcare Net Worth
Incannex Healthcare Net Worth Breakdown | IXHL |
Incannex Healthcare Net Worth Analysis
Incannex Healthcare's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Incannex Healthcare's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Incannex Healthcare's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Incannex Healthcare's net worth analysis. One common approach is to calculate Incannex Healthcare's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Incannex Healthcare's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Incannex Healthcare's net worth. This approach calculates the present value of Incannex Healthcare's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Incannex Healthcare's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Incannex Healthcare's net worth. This involves comparing Incannex Healthcare's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Incannex Healthcare's net worth relative to its peers.
Enterprise Value |
|
To determine if Incannex Healthcare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Incannex Healthcare's net worth research are outlined below:
| Incannex Healthcare had very high historical volatility over the last 90 days | |
| Incannex Healthcare may become a speculative penny stock | |
| The company reported the previous year's revenue of 12 K. Net Loss for the year was (18.46 M) with profit before overhead, payroll, taxes, and interest of 1.01 M. | |
| Incannex Healthcare Ltd currently holds about 37.5 M in cash with (15.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.68. | |
| Incannex Healthcare has a poor financial position based on the latest SEC disclosures | |
| Roughly 26.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Incannex Healthcare Reports Q3 Loss, Secures New Funding - TipRanks |
Know Incannex Healthcare's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Incannex Healthcare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Incannex Healthcare Ltd backward and forwards among themselves. Incannex Healthcare's institutional investor refers to the entity that pools money to purchase Incannex Healthcare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Tower Research Capital Llc | 2024-06-30 | 0.0 | Old Mission Capital Llc | 2024-09-30 | 0.0 | Macquarie Group Ltd | 2024-09-30 | 0.0 | Qube Research & Technologies | 2024-09-30 | 0.0 | Virtu Financial Llc | 2024-06-30 | 0.0 | Tidal Investments Llc. | 2024-09-30 | 130 K | Advisorshares Investments, Llc | 2024-09-30 | 127 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 38.9 K | Bridgeway Capital Management, Llc | 2024-09-30 | 25 K | Citadel Advisors Llc | 2024-09-30 | 24.2 K | Hrt Financial Llc | 2024-09-30 | 23.8 K |
Follow Incannex Healthcare's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 32.47 M.Market Cap |
|
Project Incannex Healthcare's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.08) | (1.14) | |
| Return On Capital Employed | (2.63) | (2.50) | |
| Return On Assets | (1.08) | (1.14) | |
| Return On Equity | (1.65) | (1.56) |
When accessing Incannex Healthcare's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Incannex Healthcare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Incannex Healthcare's profitability and make more informed investment decisions.
Evaluate Incannex Healthcare's management efficiency
Incannex Healthcare has return on total asset (ROA) of (0.5697) % which means that it has lost $0.5697 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1522) %, meaning that it created substantial loss on money invested by shareholders. Incannex Healthcare's management efficiency ratios could be used to measure how well Incannex Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -1.14. Return On Capital Employed is expected to rise to -2.5 this year. At this time, Incannex Healthcare's Total Current Assets are quite stable compared to the past year. Other Current Assets is expected to rise to about 10.9 M this year, although the value of Non Current Assets Total will most likely fall to about 802.8 K.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.69 | 0.66 | |
| Tangible Book Value Per Share | 0.69 | 0.66 | |
| Enterprise Value Over EBITDA | (2.28) | (2.39) | |
| Price Book Value Ratio | 4.25 | 4.46 | |
| Enterprise Value Multiple | (2.28) | (2.39) | |
| Price Fair Value | 4.25 | 4.46 | |
| Enterprise Value | 42.2 M | 40.1 M |
Examining the leadership quality of Incannex Healthcare Ltd offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Enterprise Value Revenue 327.7702 | Revenue 12 K | Quarterly Revenue Growth 0.296 | Revenue Per Share 0.001 | Return On Equity (1.15) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Incannex Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Incannex Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Incannex Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Barbato Luigi M. over a month ago Acquisition by Barbato Luigi M. of 100476 shares of Incannex Healthcare subject to Rule 16b-3 | ||
Barbato Luigi M. over a month ago Insider Trading | ||
Madhukar Bhalla over three months ago Insider Trading | ||
Valentine Troy over three months ago Disposition of 1951 shares by Valentine Troy of Incannex Healthcare at 16.44 subject to Rule 16b-3 | ||
Valentine Troy over three months ago Acquisition by Valentine Troy of 670000 shares of Incannex Healthcare subject to Rule 16b-3 | ||
Clark Robert over three months ago Acquisition by Clark Robert of 100000 shares of Incannex Healthcare subject to Rule 16b-3 | ||
Clark Robert over six months ago Incannex Healthcare exotic insider transaction detected |
Incannex Healthcare Earnings per Share Projection vs Actual
Incannex Healthcare Corporate Management
| Mark Bleackley | Head Officer | Profile | |
| BSc EMBA | Chief IncannexTM | Profile | |
| Rosemarie Walsh | VP Board | Profile | |
| Lekhram MSc | Chief Officer | Profile | |
| Madhukar Bhalla | CFO Sec | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incannex Healthcare Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incannex Healthcare. If investors know Incannex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incannex Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.36) | Revenue Per Share 0.001 | Quarterly Revenue Growth 0.296 | Return On Assets (0.57) | Return On Equity (1.15) |
The market value of Incannex Healthcare is measured differently than its book value, which is the value of Incannex that is recorded on the company's balance sheet. Investors also form their own opinion of Incannex Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Incannex Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incannex Healthcare's market value can be influenced by many factors that don't directly affect Incannex Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incannex Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incannex Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incannex Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.